The latest technology in ion channel drug discovery will be discussed at a two-day meeting to be held at the Nucleus Conference Facility, Chesterford Research Park, Saffron Walden, 9-10 October.
Jointly organised by Biofocus DPI and Molecular Devices, now part of MDS Analytical Technologies, the meeting will focus on screening technologies, such as automated patch-clamp, and how these have revolutionised ion channel research.
The combination of tightly-controlled assay conditions and the generation of high-fidelity screening data with enhanced throughput capacity has been instrumental in making ion channels a prime focus for drug discovery researchers.
An authoritative panel of experienced pharmaceutical industry scientists has been assembled to present their latest research and discuss the potential impact of future developments on ion channel research strategy.
In addition to the keynote lecture from Amgen, user presentations from Astrazeneca, Glaxosmithkline, Novartis and Biofocus DPI, there will be interactive workshops designed to give attendees opportunities to share knowledge and gain experience in this rapidly emerging field.
Attendees are also encouraged to bring their own posters for display.
The event is free to attend.
